CAREXERA Sdn Bhd, an adult DNA profiling expert has recently inked a memorandum of understanding (MOU) with 19 business partners to build collaborative partnerships with companies from the education, healthcare and technology industries to pave way for the way forward by shaping agile and competitive products and services in the epigenetics industry.
The 19 partners comprised four strategic partners, namely Showme Eduwav Bhd, Andorra Healthcare Bhd, Safwa Healthcare Bhd, and SuperBig Capital Bhd and three education partners, namely Akademi Generasi Mukmin Eduzone Sdn Bhd, Jazro Technology Robotics Sdn Bhd, and Read Genius Sdn Bhd.
Aside MOU signing ceremony, CareXera also rolled out its interactive mobile app which is a revolutionary tool that summarises the user’s DNA and epigenetic analysis, including the epigenetic’s biological age, inflammatory score as well as personalised lifestyle recommendations for overall improvement of health and well-being.
The mobile app which can be downloaded from Google App Store and the Apple Store is provided by CareXera Health in its effort to predict risk, prepare for interventions and preserve individual health and well-being through DNA profiling and epigenetics.
Genetic technology has revolutionised the healthcare and education ecosystem through discovering the genetic predisposition of certain health condition or disease, the genetic influence in childhood’s development, learning and educational attainment as well as epigenetic changes as a result of adverse childhood experience.
These advancements in DNA and epigenetics profiling stand out as the most promising approach in delivering an end-to-end solution through personalised healthcare along with personalised child’s development and learning.
CareXera’s goals to enrich every adult’s life by achieving healthy longevity and every child’s talent and potential through personalised intervention are in line with the UN Sustainable Development Goals (SDG) No 3 and 4.
DNA profiling uses genetic material taken from saliva to identify individuals with genetic predisposition of certain diseases. This information allows healthcare professionals to develop targeted interventions that can prevent or mitigate the effects of certain diseases.
DNA profiling can also be an invaluable tool in identifying a child’s genetic predisposition towards certain talents and abilities and their strengths and areas for improvement. The reports will allow parents and teachers to understand the underlying cause of learning difficulties and tailor educational interventions to suit the needs of each child.
This personalised approach to education can lead to better outcomes for students and help them overcome their learning challenges.
“Child DNA profiling offers exciting opportunities for parents to prevent adverse childhood experience, improve the lives of children and promote better educational and talent achievement,” commented CareXera CEO Dr Mohamad Sabri Mohd Shaffi.
“By harnessing the power of genetic technology, CareXera looks forward to a future where educators and healthcare providers can offer personalised interventions for their clients that address the unique needs of each child as well as adults.”
Added Mohamad Sabri: “Through its collaborations with industry partners and thought leaders, CareXera aims to continue pushing the boundaries of personalised healthcare, child development, and educational interventions in Malaysia and beyond.” – April 18, 2023
